Bacterial meningitis is a medical emergency characterized by infection and inflammation involving the meninges and cerebrospinal fluid (CSF). Because neurological deterioration can occur rapidly, clinicians must recognize the presentation early, obtain appropriate diagnostic studies, and initiate empiric antimicrobial therapy without unnecessary delay.
Meningitis may be classified according to its infectious cause as bacterial (pyogenic), viral (aseptic), fungal, or protozoan. Among these, acute bacterial meningitis is particularly concerning because delayed treatment can result in seizures, neurologic injury, septic shock, or death.
Microorganisms can reach the central nervous system through several pathways.
One of the most common mechanisms is bloodstream invasion. Organisms may initially colonize the nasopharynx or originate from another site of infection, subsequently entering the bloodstream and reaching the meninges.
Infections located near the central nervous system may spread directly into the meninges. Important examples include:
Trauma or structural abnormalities may create a pathway through which microorganisms can enter the CNS. Examples include skull or facial fractures, neurosurgical procedures, CSF leaks, and certain congenital craniofacial abnormalities.
The causative organism varies according to the patient’s age, immune status, vaccination history, and clinical circumstances.
Important bacterial pathogens include:
| Organism | Characteristics | Clinical Relevance |
|---|---|---|
| Streptococcus pneumoniae | Gram-positive diplococcus | Major cause of bacterial meningitis in adults |
| Neisseria meningitidis | Gram-negative diplococcus | Associated with meningococcal disease and outbreaks |
| Staphylococcus species | Gram-positive cocci | May occur with trauma, surgery, or healthcare-associated infection |
| Haemophilus influenzae type b (Hib) | Gram-negative coccobacillus | Less common where routine Hib vaccination is widespread |
The epidemiology of meningitis has changed considerably with widespread vaccination, particularly against Hib, pneumococcus, and meningococcus.
Neisseria meningitidis deserves special attention because it can spread from person to person.
The organism may colonize the human oropharynx without producing symptoms. Transmission generally occurs through respiratory droplets or direct contact with respiratory or oral secretions, particularly during close or prolonged contact.
The incubation period is generally several days but may range from approximately 1–10 days.
Patients with suspected meningococcal disease require appropriate infection-control precautions, and cases generally require prompt public-health notification according to local reporting requirements.
After effective antimicrobial treatment has been initiated, infectiousness decreases rapidly.
Clinical Pearl: Close contacts of a patient with invasive meningococcal disease may require antibiotic chemoprophylaxis even when they have no symptoms.
The classic presentation of bacterial meningitis consists of:
Fever + Headache + Nuchal Rigidity
However, relying on this triad alone can result in missed diagnoses because fewer than half of adults may present with all three findings simultaneously.
Other symptoms may include:
Some patients deteriorate very rapidly, with significant disease progression occurring within the first 24 hours.
A non-blanching petechial or purpuric rash should raise particular concern for invasive meningococcal disease.
Meningococcemia can progress rapidly and may be associated with septic shock, disseminated intravascular coagulation, and multiorgan dysfunction.
Traditional examination findings include nuchal rigidity, Kernig sign, and Brudzinski sign. These findings may support the diagnosis but are not sufficiently sensitive to exclude meningitis when absent.
With the patient lying supine, passive flexion of the neck produces involuntary flexion of the hips and knees.
Positive finding:
Neck flexion → hips and knees flex involuntarily.
The patient’s hip is flexed to approximately 90°, followed by attempted extension of the knee.
Positive finding:
Knee extension produces pain or resistance, typically involving the posterior thigh or lower back.
Clinical Pearl: A negative Kernig or Brudzinski sign does not reliably rule out meningitis. Clinical suspicion and the overall neurologic presentation remain more important.
Several CNS disorders can resemble bacterial meningitis.
Viral meningitis often produces:
The illness is often less severe than bacterial meningitis, although clinical presentation alone cannot reliably distinguish the two.
Encephalitis primarily involves inflammation of the brain parenchyma rather than the meninges.
Features suggesting encephalitis include:
Viral infections are common causes.
| Feature | Meningitis | Encephalitis |
|---|---|---|
| Primary structure affected | Meninges/CSF | Brain parenchyma |
| Headache | Common | Common |
| Neck stiffness | More characteristic | May be absent |
| Altered mental status | Possible | Prominent |
| Seizures | Possible | Common |
| Focal neurologic deficits | Less typical | More concerning |
Other important differential diagnoses include brain abscess, stroke, CNS vasculitis, drug-induced meningitis, meningeal malignancy, and complications of sinus or mastoid infection.
Lumbar puncture (LP) with CSF analysis is central to establishing the diagnosis.
Typical studies may include:
The CSF pattern can provide important clues regarding the underlying cause.
| Parameter | Normal CSF | Bacterial Meningitis | Viral Meningitis |
|---|---|---|---|
| Opening pressure | Normal | Usually elevated | Normal or mildly elevated |
| WBC count | <5 cells/mm³ | Markedly elevated | Elevated |
| Predominant cells | Mononuclear cells | Usually neutrophils | Usually lymphocytes |
| Glucose | Normal | Decreased | Usually normal |
| Protein | Normal | Elevated | Normal to mildly elevated |
A particularly important clue for bacterial meningitis is:
High neutrophilic WBC count + low CSF glucose + high CSF protein + elevated opening pressure
Clinical and microbiologic findings must still be interpreted together because CSF patterns can overlap, especially early in disease.
No.
Neuroimaging does not directly establish the diagnosis of meningitis. CT or MRI may be required before LP in selected patients when there is concern for conditions that could make immediate lumbar puncture unsafe or when structural CNS pathology is suspected.
Imaging may identify:
The most important principle is:
Do not delay appropriate empiric antimicrobial therapy simply while waiting for neuroimaging or lumbar puncture when bacterial meningitis is strongly suspected.
Blood cultures should generally be obtained promptly when feasible, followed by empiric treatment when diagnostic procedures would otherwise cause a significant delay.
Acute bacterial meningitis requires rapid hospital-based treatment.
Management generally includes:
Adjunctive corticosteroid therapy, particularly dexamethasone, may also be appropriate in selected cases and is most effective when administered before or with the first antimicrobial dose.
When herpes simplex virus encephalitis is part of the differential diagnosis, empiric IV acyclovir may be initiated while diagnostic testing is pending.
Close contacts of a patient with invasive N. meningitidis disease may require antibiotic prophylaxis because of the risk of secondary infection.
Examples of significant exposure can include household contacts and individuals with direct exposure to the patient’s oral or respiratory secretions.
Common prophylactic agents include:
The choice of medication depends on factors such as age, pregnancy status, contraindications, drug interactions, and local antimicrobial resistance.
Vaccination does not necessarily eliminate the need for chemoprophylaxis following a qualifying exposure.
Vaccination has dramatically reduced several major causes of bacterial meningitis.
Pneumococcal vaccines protect against invasive disease caused by Streptococcus pneumoniae. Recommendations depend on age, previous vaccination, and medical risk factors.
Routine childhood vaccination against Haemophilus influenzae type b has greatly reduced invasive Hib disease and childhood bacterial meningitis.
Additional vaccination may be recommended for certain high-risk individuals, including some patients with anatomical or functional asplenia or other immunocompromising conditions.
Meningococcal vaccines provide protection against several clinically important serogroups.
MenACWY vaccines target serogroups:
A, C, W, and Y
MenB vaccines target:
Serogroup B
Vaccination may be particularly important for adolescents and young adults and for individuals with specific medical, occupational, travel, residential, or outbreak-related risks.
Because vaccine schedules evolve, clinicians should follow current national or regional immunization recommendations rather than relying solely on older product-specific schedules.
Bacterial meningitis should remain high on the differential diagnosis when a patient presents with fever, severe headache, neck stiffness, altered mental status, or new-onset seizures.
Remember:
Suspect early. Culture promptly. Treat immediately.
Bacterial meningitis can progress from an acute febrile illness to severe neurologic dysfunction and systemic instability within hours. Rapid clinical recognition, appropriate CSF evaluation, immediate antimicrobial therapy, and prevention of secondary cases are therefore essential components of effective management.
Educational content only. Clinical management, antimicrobial selection, vaccination, and post-exposure prophylaxis should follow current local guidelines and patient-specific factors.
